print small

Participating Countries:

Algeria

Argentina

Australia

Austria

Belgium

Bosnia and Herzegovina

Bulgaria

Croatia

Czech Republic

Denmark

Finland

France

FYR of Macedonia

Germany

Greece

Iceland

Ireland

Israel

Italy

Lithuania

Morocco

Netherlands

New Zealand

Poland

Portugal

Romania

Russian Federation

Serbia

Slovenia

Spain

Sweden

Switzerland

Turkey

Ukraine

United Kingdom

United States

Member area provided by LTFE
COST is supported by the EU Framework Programme Horizon 2020
This website is supported by COST

University of Canterbury research to help improve cancer patient drug delivery

15/11/2013


Tell your friend  | 

Read a short news item on EU - New Zealand cooperation for developing new technologies that will help improve the delivery of drugs to skin cancer patients by administering the drug directly through the skin.

The short summary outlines colaboration within (as well as outside) the scope of the COST TD1104 Action and can be found on a New Zealand-based news portal www.voxy.co.nz. Direct link.


Project Office

Working groups

Steering Committee

Founding members

DC Rapporteurs

Related sites: